The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Treatment for mitochondrial disorders
Open accessAbstract
BACKGROUND: Mitochondrial respiratory chain disorders are the most prevalent group of inherited neurometabolic diseases. They present with central and peripheral neurological features usually in association with other organ involvement including the eye, the heart, the liver, and kidneys, diabetes mellitus and sensorineural deafness. Current treatment is largely supportive and the disorders progress relentlessly causing significant morbidity and premature death. Vitamin supplements, pharmacological agents and exercise therapy have been used in isolated cases and small clinical trials, but the efficacy of these interventions is unclear. The first review was carried out in 2003, and identified six clinical trials. This major update was carried out to identify new studies and grade the original studies for potential bias in accordance with revised Cochrane Collaboration guidelines. OBJECTIVES: To determine whether there is objective evidence to support the use of current treatments for mitochondrial disease. SEARCH METHODS: We searched the Cochrane Neuromuscular Disease Group Specialized Register (4 July 2011), CENTRAL (2011, Issue 2, MEDLINE (1966 to July 2011), and EMBASE (January 1980 to July 2011), and contacted experts in the field. SELECTION CRITERIA: We included randomised controlled trials (including cross-over studies). Two of the authors independently selected abstracts for further detailed review. Further review was performed independently by all five authors to decide which trials fit the inclusion criteria and graded risk of bias. Participants included males and females of any age with a confirmed diagnosis of mitochondrial disease based upon muscle histochemistry, respiratory chain complex analysis of tissues or cell lines or DNA studies. Interventions included any pharmacological agent, dietary modification, nutritional supplement, exercise therapy or other treatment. The review authors excluded studies at high risk of bias in any category. The primary outcome measures included an change in muscle strength and/or endurance, or neurological clinical features. Secondary outcome measures included quality of life assessments, biochemical markers of disease and negative outcomes. DATA COLLECTION AND ANALYSIS: Two of the authors (GP and PFC) independently identified studies for further evaluation from all abstracts within the search period. For those studies identified for further review, all five authors then independently assessed which studies met the entry criteria. For the included studies, we extracted details of the number of randomised participants, treatment, study design, study category, allocation concealment and other risk of bias criteria, and participant characteristics. Analysis was based on intention-to-treat data. We planned to use meta-analysis, but this did not prove necessary. MAIN RESULTS: The authors reviewed 1335 abstracts, and from these identified 21 potentially eligible abstracts. Upon detailed review, 12 studies fulfilled the entry criteria. Of these, eight were new studies that had been published since the previous version of this review. Two studies which were included in the previous version of this review were excluded because of potential for bias. The comparability of the included studies is extremely low because of differences in the specific diseases studied, differences in the therapeutic agents used, dosage, study design, and outcomes. The methodological quality of included studies was generally high, although risk of bias was unclear in random sequence generation and allocation concealment for most studies. Otherwise, the risk of bias was low for most studies in the other categories. Serious adverse events were uncommon, except for peripheral nerve toxicity in a long-term trial of dichloroacetate (DCA) in adults.One trial studied high-dose coenzyme Q10 without clinically meaningful improvement (although there were multiple biochemical, physiologic, and neuroimaging outcomes, in 30 participants). Three trials used creatine monohydrate alone, with one reporting evidence of improved measures of muscle strength and post-exercise lactate, but the other two reported no benefit (total of 38 participants). One trial studied the effects of a combination of coenzyme Q10, creatine monohydrate, and lipoic acid and reported a statistically significant improvement in biochemical markers and peak ankle dorsiflexion strength, but overall no clinical improvement in 16 participants. Five trials studied the effects of DCA: three trials in children showed a statistically significant improvement in secondary outcome measures of mitochondrial metabolism (venous lactate in three trials, and magnetic resonance spectroscopy (MRS) in one trial; total of 63 participants). One trial of short-term DCA in adults demonstrated no clinically relevant improvement (improved venous lactate but no change in physiologic, imaging, or questionnaire findings, in eight participants). One longer-term DCA t
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,636
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Mitochondrial fusion and fission in cell life and death
Westermann, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3013 · Cited by 2,002 · cited 1×
“Disorders of mitochondrial fusion and fission also result in secondary mitochondrial dysfunction (Westermann 2010).”
BackgroundDeletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
Holt, I. J., Harding, A. E., & Morgan-Hughes, J. A. (1988) · Nature · doi:10.1038/331717a0 · Cited by 1,846
Mitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,661
Mitochondrial DNA Deletions in Progressive External Ophthalmoplegia and Kearns-Sayre Syndrome
Moraes, C. T., DiMauro, S., Zeviani, M., Lombes, A., Shanske, S., Miranda, A. F., Nakase, H., Bonilla, E., Werneck, L. C., Servidei, S., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905183202001 · Cited by 1,032
Thymidine Phosphorylase Gene Mutations in MNGIE, a Human Mitochondrial Disorder
Nishino, I., Spinazzola, A., & Hirano, M. (1999) · Science · doi:10.1126/science.283.5402.689 · Cited by 903
Spelbrink, J. N., Li, F.-Y., Tiranti, V., Nikali, K., Yuan, Q.-P., Tariq, M., Wanrooij, S., Garrido, N., Comi, G., Morandi, L., et al. (2001) · Nature Genetics · doi:10.1038/90058 · Cited by 882
Van Goethem, G., Dermaut, B., Löfgren, A., Martin, J.-J., & Van Broeckhoven, C. (2001) · Nature Genetics · doi:10.1038/90034 · Cited by 841
Deletions of mitochondrial DNA in Kearns‐Sayre syndrome
Zeviani, M., Moraes, C. T., DiMauro, S., Nakase, H., Bonilla, E., Schon, E. A., & Rowland, L. P. (1988) · Neurology · doi:10.1212/wnl.38.9.1339 · Cited by 735
Role of Adenine Nucleotide Translocator 1 in mtDNA Maintenance
Kaukonen, J., Juselius, J. K., Tiranti, V., Kyttälä, A., Zeviani, M., Comi, G. P., Keränen, S., Peltonen, L., & Suomalainen, A. (2000) · Science · doi:10.1126/science.289.5480.782 · Cited by 636
Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy
Saada, A., Shaag, A., Mandel, H., Nevo, Y., Eriksson, S., & Elpeleg, O. (2001) · Nature Genetics · doi:10.1038/ng751 · Cited by 628
Schapira, A. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68970-8 · Cited by 591
Mandel, H., Szargel, R., Labay, V., Elpeleg, O., Saada, A., Shalata, A., Anbinder, Y., Berkowitz, D., Hartman, C., Barak, M., et al. (2001) · Nature Genetics · doi:10.1038/ng746 · Cited by 588
Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics
Mootha, V. K., Lepage, P., Miller, K., Bunkenborg, J., Reich, M., Hjerrild, M., Delmonte, T., Villeneuve, A., Sladek, R., Xu, F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716699 · Cited by 571
AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome
Stevens, J. C. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12 · Cited by 518
Shoffner, J. M., Lott, M. T., Voljavec, A. S., Soueidan, S. A., Costigan, D. A., & Wallace, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7952 · Cited by 505
Prevalence of mitochondrial DNA disease in adults
Schaefer, A. M., McFarland, R., Blakely, E. L., He, L., Whittaker, R. G., Taylor, R. W., Chinnery, P. F., & Turnbull, D. M. (2008) · Annals of Neurology · doi:10.1002/ana.21217 · Cited by 494
Self-citationMinimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487
POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion
Naviaux, R. K., & Nguyen, K. V. (2004) · Annals of Neurology · doi:10.1002/ana.20079 · Cited by 460
Mitochondrial DNA Mutations and Pathogenesis
Schon, E. A., Bonilla, E., & DiMauro, S. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022685929755 · Cited by 424
Mitochondrial DNA mutations in human disease
DiMauro, S., & Schon, E. A. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1392 · Cited by 417
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.
Ogasahara, S., Engel, A. G., Frens, D., & Mack, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2379 · Cited by 366
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
Kaufmann, P., Engelstad, K., Wei, Y., Jhung, S., Sano, M. C., Shungu, D. C., Millar, W. S., Hong, X., Gooch, C. L., Mao, X., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000196641.05913.27 · Cited by 365
Mitochondrial respiratory chain disorders I: mitochondrial DNA defects
Leonard, J., & Schapira, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05225-3 · Cited by 363
Darin, N., Oldfors, A., Moslemi, A., Holme, E., & Tulinius, M. (2001) · Annals of Neurology · doi:10.1002/ana.75 · Cited by 362
Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency
Rötig, A., Appelkvist, E.-L., Geromel, V., Chretien, D., Kadhom, N., Edery, P., Lebideau, M., Dallner, G., Munnich, A., Ernster, L., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02531-9 · Cited by 356
l -Arginine improves the symptoms of strokelike episodes in MELAS
Koga, Y., Akita, Y., Nishioka, J., Yatsuga, S., Povalko, N., Tanabe, Y., Fujimoto, S., & Matsuishi, T. (2005) · Neurology · doi:10.1212/01.wnl.0000151976.60624.01 · Cited by 312
Eleff, S., Kennaway, N. G., Buist, N. R., Darley-Usmar, V. M., Capaldi, R. A., Bank, W. J., & Chance, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3529 · Cited by 273
Lamantea, E., Tiranti, V., Bordoni, A., Toscano, A., Bono, F., Servidei, S., Papadimitriou, A., Spelbrink, H., Silvestri, L., Casari, G., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10278 · Cited by 270
Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in Children
Stacpoole, P. W., Kerr, D. S., Barnes, C., Bunch, S. T., Carney, P. R., Fennell, E. M., Felitsyn, N. M., Gilmore, R. L., Greer, M., Henderson, G. N., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-1226 · Cited by 259
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders
Rodriguez, M. C., MacDonald, J. R., Mahoney, D. J., Parise, G., Beal, M. F., & Tarnopolsky, M. A. (2007) · Muscle & Nerve · doi:10.1002/mus.20688 · Cited by 255
Early Coenzyme Q10 Supplementation in Primary Coenzyme Q10 Deficiency
Montini, G., Malaventura, C., & Salviati, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0800582 · Cited by 253
Familial cerebellar ataxia with muscle coenzyme Q10 deficiency
Musumeci, O., Naini, A., Slonim, A. E., Skavin, N., Hadjigeorgiou, G. L., Krawiecki, N., Weissman, B. M., Tsao, C.-Y., Mendell, J. R., Shanske, S., et al. (2001) · Neurology · doi:10.1212/wnl.56.7.849 · Cited by 252
Taivassalo, T., Gardner, J. L., Taylor, R. W., Schaefer, A. M., Newman, J., Barron, M. J., Haller, R. G., & Turnbull, D. M. (2006) · Brain · doi:10.1093/brain/awl282 · Cited by 220
Self-citationTaivassalo, T., Shoubridge, E. A., Chen, J., Kennaway, N. G., DiMauro, S., Arnold, D. L., & Haller, R. G. (2001) · Annals of Neurology · doi:10.1002/ana.1050 · Cited by 212
Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
Jeppesen, T. D., Schwartz, M., Olsen, D. B., Wibrand, F., Krag, T., Duno, M., Hauerslev, S., & Vissing, J. (2006) · Brain · doi:10.1093/brain/awl149 · Cited by 211
Epidemiology and treatment of mitochondrial disorders
Chinnery, P. F., & Turnbull, D. M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1426 · Cited by 203
Self-citationMitochondrial encephalomyopathy with coenzyme Q 10 deficiency
Sobreira, C., Hirano, M., Shanske, S., Keller, R. K., Haller, R. G., Davidson, E., Santorelli, F. M., Miranda, A. F., Bonilla, E., Mojon, D. S., et al. (1997) · Neurology · doi:10.1212/wnl.48.5.1238 · Cited by 194
Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options
Thorburn, D. R., & Dahl, H. M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1380 · Cited by 182
Self-citationMitochondrial DNA mutations in diseases of energy metabolism
Wallace, D. C. (1994) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00763096 · Cited by 173
Resistance training in patients with single, large-scale deletions of mitochondrial DNA
Murphy, J. L., Blakely, E. L., Schaefer, A. M., He, L., Wyrick, P., Haller, R. G., Taylor, R. W., Turnbull, D. M., & Taivassalo, T. (2008) · Brain · doi:10.1093/brain/awn252 · Cited by 167
Self-citationDe Stefano, N., Matthews, P. M., Ford, B., Genge, A., Karpati, G., & Arnold, D. L. (1995) · Neurology · doi:10.1212/wnl.45.6.1193 · Cited by 166
Creatine monohydrate increases strength in patients with neuromuscular disease
Tarnopolsky, M., & Martin, J. (1999) · Neurology · doi:10.1212/wnl.52.4.854 · Cited by 165
Ihara, Y., Namba, R., Kuroda, S., Sato, T., & Shirabe, T. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90112-3 · Cited by 161
Treatment of Kearns‐Sayre syndrome with coenzyme Q 10
Ogasahara, S., Nishikawa, Y., Yorifuji, S., Soga, F., Nakamura, Y., Takahashi, M., Hashimoto, S., Kono, N., & Tarui, S. (1986) · Neurology · doi:10.1212/wnl.36.1.45 · Cited by 158
Matthews, P. M., Andermann, F., Silver, K., et al. (1993) · Neurology · doi:10.1212/wnl.43.12.2484 · Cited by 147
Effects of aerobic training in patients with mitochondrial myopathies
Taivassalo, T., Stefano, N. D., Argov, Z., Matthews, P. M., Chen, J., Genge, A. L., Karpati, G., & Arnold, D. L. (1998) · Neurology · doi:10.1212/wnl.50.4.1055 · Cited by 139
Mashima, Y., Kigasawa, K., Wakakura, M., & Oguchi, Y. (2000) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-200020030-00006 · Cited by 138
Treatment for mitochondrial disorders
Chinnery, P. F., Majamaa, K., Turnbull, D. M., & Thorburn, D. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004426.pub2 · Cited by 138
Self-citationEvaluation of Long-term Treatment of Children With Congenital Lactic Acidosis With Dichloroacetate
Stacpoole, P. W., Gilbert, L. R., Neiberger, R. E., Carney, P. R., Valenstein, E., Theriaque, D. W., & Shuster, J. J. (2008) · PEDIATRICS · doi:10.1542/peds.2007-2062 · Cited by 131
A randomized trial of coenzyme Q 10 in mitochondrial disorders
Glover, E. I., Martin, J., Maher, A., Thornhill, R. E., Moran, G. R., & Tarnopolsky, M. A. (2010) · Muscle & Nerve · doi:10.1002/mus.21758 · Cited by 129
MELAS syndrome with mitochondrial tRNA Leu[UUR] mutation
Penn, A. M. W., Lee, J. W. K., Thuillier, P., Wagner, M., Maclure, K. M., Menard, M. R., Hall, L. D., & Kennaway, N. G. (1992) · Neurology · doi:10.1212/wnl.42.11.2147 · Cited by 124
Macmillan, C., Lach, B., & Shoubridge, E. A. (1993) · Neurology · doi:10.1212/wnl.43.8.1586 · Cited by 120
Suzuki, S., Hinokio, Y., Ohtomo, M., Hirai, M., Hirai, A. M., Chiba, M., Kasuga, S., Sato, Y., Akai, H., & Toyota, T. (1998) · Diabetologia · doi:10.1007/s001250050950 · Cited by 116
Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial
Bresolin, N., Doriguzzi, C., Ponzetto, C., Angelini, C. I., Moroni, I., Castelli, E., Cossutta, E., Binda, A., Gallanti, A., Gabellini, S., et al. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90015-f · Cited by 108
Coenzyme Q10 Treatment in Mitochondrial Encephalomyopathies
Lang, C. J. G., Sittl, H., & Erbguth, F. (2008) · European Neurology · doi:10.1159/000117445 · Cited by 106
Bendahan, D., Desnuelle, C., Vanuxem, D., Confort-Gouny, S., Figarella-Branger, D., Pellissier, J. F., Kozak-Ribbens, G., Pouget, J., Serratrice, G., & Cozzone, P. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1203 · Cited by 104
Clinical features, investigation, and management of patients with defects of mitochondrial DNA
Chinnery, P. F., & Turnbull, D. M. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.5.559 · Cited by 104
Self-citationDahl, H. M. (1998) · The American Journal of Human Genetics · doi:10.1086/302169 · Cited by 102
Nishikawa, Y., Takahashi, M. M., Yorifuji, S., Nakamura, Y., Ueno, S., Tarui, S., Kozuka, T., & Nishimura, T. (1989) · Neurology · doi:10.1212/wnl.39.3.399 · Cited by 100
Treatment of complex I deficiency with riboflavin
Bernsen, P. L. J. A., Gabreëls, F. J. M., Ruitenbeek, W., & Hamburger, H. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90108-b · Cited by 98
Exercise training in mitochondrial myopathy: A randomized controlled trial
Cejudo, P., Bautista, J., Montemayor, T., Villagómez, R., Jiménez, L., Ruiz, F. Ó., Campos, Y., Sánchez, H., & Arenas, J. (2005) · Muscle & Nerve · doi:10.1002/mus.20368 · Cited by 98
Remission of Leber's hereditary optic neuropathy with idebenone
Mashima, Y., Hiida, Y., & Oguchi, Y. (1992) · The Lancet · doi:10.1016/0140-6736(92)91442-b · Cited by 80
Cortelli, P., Montagna, P., Pierangeli, G., Lodi, R., Barboni, P., Liguori, R., Carelli, V., Iotti, S., Zaniol, P., Lugaresi, E., et al. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00311-5 · Cited by 77
Abe, K., Fujimura, H., Nishikawa, Y., Yorifuji, S., Mezaki, T., Hirono, N., Nishitani, N., & Kameyama, M. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb03962.x · Cited by 76
A placebo-controlled crossover trial of creatine in mitochondrial diseases
Klopstock, T., Querner, V., Schmidt, F., Gekeler, F., Walter, M., Hartard, M., Dipl-Stat, M. H., Gasser, T., Pongratz, D., Straube, A., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1748 · Cited by 72
Mancuso, M., Orsucci, D., LoGerfo, A., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5409-7 · Cited by 72
Abe, K., Matsuo, Y., Kadekawa, J., Inoue, S., & Yanagihara, T. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00296-2 · Cited by 67
Chronic treatment of mitochondrial disease patients with dichloroacetate
Barshop, B. A., Naviaux, R. K., McGowan, K. A., Levine, F., Nyhan, W. L., Loupis-Geller, A., & Haas, R. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.06.009 · Cited by 66
Kornblum, C., Schröder, R., Müller, K., Vorgerd, M., Eggers, J., Bogdanow, M., Papassotiropoulos, A., Fabian, K., Klockgether, T., & Zange, J. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00970.x · Cited by 65
Folkers, K., Wolaniuk, J., Simonsen, R., Morishita, M., & Vadhanavikit, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4513 · Cited by 64
Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies
Komura, K., Hobbiebrunken, E., Wilichowski, E. K. G., & Hanefeld, F. A. (2003) · Pediatric Neurology · doi:10.1016/s0887-8994(02)00469-1 · Cited by 61
Nuclear power and mitochondrial disease
DiMauro, S., & Schon, E. A. (1998) · Nature Genetics · doi:10.1038/883 · Cited by 58
Barbiroli, B., Medori, R., Tritschler, H., Klopstock, T., Seibel, P., Reichmann, H., Iotti, S., Lodi, R., & Zaniol, P. (1995) · Journal of Neurology · doi:10.1007/bf00873552 · Cited by 55
Recent Advances in the Genetics of Mitochondrial Encephalopathies
Tucker, E. J., Compton, A. G., & Thorburn, D. R. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0112-8 · Cited by 53
Self-citationCPEO and carnitine deficiency overlapping in MELAS syndrome
Hsu, C.-C., Chuang, Y.-H., Tsai, J.-L., Jong, H.-J., Shen, Y., Huang, H.-L., Chen, H., Lee, H., Pang, C., Wei, Y., et al. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb01697.x · Cited by 49
Panetta, J. D., Smith, L. J., & Boneh, A. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000037354.66587.38 · Cited by 47
Pathogenic mutations of nuclear genes associated with mitochondrial disorders
Zhu, X., Peng, X.-R., Guan, M., & Yan, Q. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmn021 · Cited by 46
Mitochondrial myopathies: developments in treatment
Hassani, A., Horváth, R., & Chinnery, P. F. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833d1096 · Cited by 44
Self-citationDichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS
Mori, M., Yamagata, T., Goto, T., Saito, S., & Momoi, M. Y. (2004) · Brain and Development · doi:10.1016/j.braindev.2003.12.009 · Cited by 43
Duncan, G. E., Perkins, L. A., Theriaque, D. W., Neiberger, R. E., & Stacpoole, P. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031684 · Cited by 37
Exercise intolerance in mitochondrial myopathy is not related to lactic acidosis
Vissing, J., Gansted, U., & Quistorff, B. (2001) · Annals of Neurology · doi:10.1002/ana.1026 · Cited by 35
Gold, R., Seibel, P., Reinelt, G., Schindler, R., Landwehr, P., Beck, A., & Reichmann, H. (2008) · European Neurology · doi:10.1159/000117246 · Cited by 34
Metabolic interventions against complex I deficiency in MELAS syndrome
Majamaa, K., Rusanen, H., Remes, A. M., & Hassinen, I. E. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6111-8_45 · Cited by 33
Self-citationTherapy of complex I deficiency: Peripheral neuropathy during dichloroacetate therapy
Kurlemann, G., Paetzke, I., Möller, H. E., Masur, H., Schuierer, G. R., Weglage, J., & Koch, H. G. (1995) · European Journal of Pediatrics · doi:10.1007/bf01957508 · Cited by 33
Mitsui, T., Umaki, Y., Nagasawa, M., Akaike, M., Aki, K., Azuma, H., Ozaki, S., Odomi, M., & Matsumoto, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0553-5 · Cited by 32
Genetic Counseling and Prenatal Diagnosis for mtDNA Disease
Chinnery, P. F., Howell, N., Lightowlers, R. N., & Turnbull, D. M. (1998) · The American Journal of Human Genetics · doi:10.1086/302157 · Cited by 31
Self-citationMitochondrial Diseases: A Cross-Talk Between Mitochondrial and Nuclear Genomes
Spinazzola, A., & Zeviani, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-2813-6_6 · Cited by 28
In-vitro genetic modification of mitochondrial function
Taylor, R. W., Chinnery, P. F., Turnbull, D. M., & Lightowlers, R. N. (2000) · Human Reproduction · doi:10.1093/humrep/15.suppl_2.79 · Cited by 27
Self-citationMetabolic interventions against complex I deficiency in MELAS syndrome
Majamaa, K., Rusanen, H., Remes, A. M., & Hassinen, I. E. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006833200371 · Cited by 27
Self-citationReversible ophthalmoplegia in CPEO
Dunlop, I. S., & Dunlop, P. (1995) · Australian and New Zealand Journal of Ophthalmology · doi:10.1111/j.1442-9071.1995.tb00164.x · Cited by 7
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Cited by
Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388
Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production
Doenst, T., Nguyen, T. D., & Abel, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300376 · Cited by 1,111
Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.05.007 · Cited by 846
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 827
Mitochondrial disorders as windows into an ancient organelle
Vafai, S. B., & Mootha, V. K. (2012) · Nature · doi:10.1038/nature11707 · Cited by 737
Metadata
- Authors
- Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D., & Chinnery, P. F.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2012-04-18
- Volume
- 2012
- Issue
- 4
- Pages
- CD004426-CD004426
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1551444218
- Cited by
- 492
- References
- 93
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.